These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 6782008

  • 1. Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes.
    Czarnetzki BM.
    Immunobiology; 1980 Apr; 157(1):62-6. PubMed ID: 6782008
    [Abstract] [Full Text] [Related]

  • 2. Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187.
    Czarnetzki BM, König W, Lichtenstein LM.
    J Immunol; 1976 Jul; 117(1):229-34. PubMed ID: 778263
    [Abstract] [Full Text] [Related]

  • 3. Neutrophil-derived eosinophil chemotactic factor production induced by immune complexes.
    Czarnetzki BM, Schulz W.
    Int Arch Allergy Appl Immunol; 1981 Jul; 64(1):51-9. PubMed ID: 6778829
    [Abstract] [Full Text] [Related]

  • 4. Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis.
    König W, Czarnetzki BM, Lichtenstein LM.
    J Immunol; 1976 Jul; 117(1):235-41. PubMed ID: 932426
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of ECF generation, secretion and inactivation.
    König W, Tesch H, Frickhofen N.
    Monogr Allergy; 1979 Jul; 14():203-11. PubMed ID: 388196
    [No Abstract] [Full Text] [Related]

  • 6. The mediation of tissue eosinophilia in hypersensitivity reactions. IV. Production of delayed eosinophil chemotactic factor-a by peritoneal exudate cells from sensitized guinea-pigs in vitro.
    Hirashima M, Hirotsu Y, Hayashi H.
    Immunology; 1983 Jan; 48(1):69-77. PubMed ID: 6848455
    [Abstract] [Full Text] [Related]

  • 7. In vitro generation of eosinophil chemotactic factor from human and murine mononuclear phagocytes.
    Czarnetzki BM.
    Scand J Immunol; 1981 Jan; 13(6):511-6. PubMed ID: 6797047
    [Abstract] [Full Text] [Related]

  • 8. Effect of platelet activating factor on leukocytes. II. Enhancement of eosinophil chemotactic factor and beta-glucuronidase release.
    Czarneztki BM.
    Chem Phys Lipids; 1982 Oct; 31(2):205-11. PubMed ID: 6814773
    [Abstract] [Full Text] [Related]

  • 9. Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes.
    Czarnetzki BM, König W, Lichtenstein LM.
    Int Arch Allergy Appl Immunol; 1978 Oct; 56(5):398-408. PubMed ID: 344231
    [Abstract] [Full Text] [Related]

  • 10. Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid.
    König W, Tesch H, Frickhofen N.
    Eur J Immunol; 1978 Jun; 8(6):434-7. PubMed ID: 352712
    [Abstract] [Full Text] [Related]

  • 11. Generation and release of eosinophil chemotactic factor from human polymorphonuclear leukocytes.
    König W, Czarnetzki BM, Lichtenstein LM.
    Monogr Allergy; 1977 Jun; 12():198-212. PubMed ID: 335215
    [No Abstract] [Full Text] [Related]

  • 12. Selective regulation of chemotactic lymphokine production. I. Selective potentiation of eosinophil chemotactic lymphokine production in alum hydroxy gel- and Bordetella pertussis vaccine-treated guinea pigs.
    Sakata K, Tashiro K, Hirashima M, Hayashi H.
    J Immunol; 1985 Nov; 135(5):3463-7. PubMed ID: 2864377
    [Abstract] [Full Text] [Related]

  • 13. Eosinophil chemotactic factor released from murine bone marrow derived cultured mast cells.
    Abe T, Nawa Y.
    Arerugi; 1990 Feb; 39(2 Pt 1):69-74. PubMed ID: 2141250
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of polymorphonuclear-neutrophil derived eosinophil chemotactic factor by human serum.
    König W, Czarnetzki BM.
    Int Arch Allergy Appl Immunol; 1978 Feb; 57(5):399-410. PubMed ID: 352966
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the eosinophil chemotactic factor (ECF) release from various cells and their subcellular components by phospholipids.
    König W, Kroegel C, Pfeiffer P, Tesch H.
    Int Arch Allergy Appl Immunol; 1981 Feb; 65(4):417-31. PubMed ID: 6788714
    [Abstract] [Full Text] [Related]

  • 16. Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.
    Goetzl EJ, Tashjian AH, Rubin RH, Austen KF.
    J Clin Invest; 1978 Mar; 61(3):770-80. PubMed ID: 641154
    [Abstract] [Full Text] [Related]

  • 17. Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation.
    König W, Frickhofen N, Tesch H.
    Immunology; 1979 Apr; 36(4):733-42. PubMed ID: 437847
    [Abstract] [Full Text] [Related]

  • 18. The effects of a soluble factor released by sensitized mononuclear cells incubated with S. haematobium ova on eosinophil migration.
    Wadee AA, Sher R.
    Immunology; 1980 Dec; 41(4):989-95. PubMed ID: 7461720
    [Abstract] [Full Text] [Related]

  • 19. Phospholipase A2 and arachidonic acid: a common link in the generation of the eosinophil chemotactic factor (ECF) from human PMN by various stimuli.
    Tesch H, König W.
    Scand J Immunol; 1980 Dec; 11(4):409-18. PubMed ID: 6770461
    [Abstract] [Full Text] [Related]

  • 20. Eosinophil chemotactic factor (ECF). III. Generation in human peripheral leukocytes.
    König W, Czarnetzki BM, Lichtenstein LM.
    Int Arch Allergy Appl Immunol; 1978 Dec; 56(4):364-75. PubMed ID: 344230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.